ETANERCEPT
etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes],
1 pack
ETANERCEPT (5734T)
5734T
Manner of administration:Injection
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 12 months)
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 12 months)
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after
a break in biological medicine of less than 12 months) or Initial 3 (recommencement
of treatment after a break in biological medicine of more than 12 months) - balance
of supply
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $371.81 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Enbrel | |||||